Molecular pathology in the preclinical development of biopharmaceuticals

Advances in cell and molecular biology have engendered a wide range of tech niques that can be used to study the molecular events that underlie the cau se of disease, thus producing a new field of study called "molecular pathol ogy." These techniques can be either slide-based or non-slide-based (soluti on-based). The slide-based techniques include immunohistochemistry, in situ hybridization, and in situ polymerase chain reaction; pathologists play a unique role in the administration of these techniques because of their abil ity to interpret the end product (i.e., the slide). In this manuscript, we briefly discussed the use and impact of these slide-based techniques within all phases of drug development in the pharmaceutical industry.